Clinical Trials Logo

Carcinoma Breast clinical trials

View clinical trials related to Carcinoma Breast.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03113825 Completed - Clinical trials for Breast Cancer Female

Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Start date: July 5, 2017
Phase: Phase 2
Study type: Interventional

Phase 2, open-label study of AVB-620 in women with primary, nonrecurrent and nonmetastatic breast cancer undergoing surgery.

NCT ID: NCT03002766 Completed - Carcinoma Breast Clinical Trials

Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast

DCIS
Start date: March 2000
Phase: Phase 2
Study type: Interventional

By this non-randomized prospective study, it's evaluated the outcome of patients underwent BCS for DCIS at whom an established score system to address adjuvant therapies have been prospectively applied, according to the wideness of free margins. Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.

NCT ID: NCT01849133 Completed - Carcinoma Breast Clinical Trials

Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy

ELIOT
Start date: November 2000
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of exclusive intraoperative radiation therapy after conserving surgery in early-stage breast cancer compared with whole breast radiotherapy. The primary outcome was the rate of ipsilateral true recurrence ( any recurrence at or close to primary tumor bed) and new ipsilateral tumors ( any recurrence occurring in quadrants other than the previous one) and the recurrence free survival.

NCT ID: NCT00043394 Completed - Carcinoma, Breast Clinical Trials

CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

Start date: September 2002
Phase: Phase 2
Study type: Interventional

To determine the safety and efficacy of CPG 7909 Injection given with Herceptin to patients with metastatic breast cancer.